Palliative Care / End-of-Life Care

Palliative care changes the question. It is no longer about what will cure the illness, but about what will make the remaining time as comfortable, lucid and dignified as possible. Cannabinoid therapy fits that goal unusually well, because a single medicine can address several of the symptoms that cluster at the end of life rather than requiring a separate drug for each.

Pain

Cannabis has the largest evidence base of any medical cannabis indication in pain management, with multiple randomised controlled trials showing significant reductions in patient-reported pain. Two features matter especially in palliative settings. There is no risk of fatal overdose. And because cannabinoids act on an entirely separate receptor system from opioids, they can be used alongside opioid therapy, often allowing the opioid dose to be reduced. For families worried about sedation and lost lucidity in a patient's final weeks, that reduction can be significant.

Nausea and Vomiting

This is the best-established cannabinoid indication in oncology, and it carries directly into palliative care. Cannabinoids appear to downregulate the chemoreceptor activity that triggers nausea and vomiting, reducing both frequency and severity. Evidence has accumulated since the 1980s, and low-dose cannabis has been shown to improve the effectiveness of conventional anti-emetics rather than compete with them. The benefit extends beyond chemotherapy to nausea associated with radiation therapy and post-surgical recovery.

Appetite, Weight and Cachexia

THC promotes appetite and reduces wasting in patients with cancer-related anorexia-cachexia and in patients with AIDS. Combined with reduced nausea, this is often what allows someone to eat a meal with their family, which patients and relatives alike tend to value out of all proportion to its clinical weight.

Anxiety, Mood and Sleep

Serious illness brings fear, low mood and broken sleep, and these are not lesser symptoms. Cannabinoids influence serotonin signalling and receptors governing anxiety and mood, and patients consistently report calmer nights, reduced anxiety and improved sleep quality. Where a patient is also managing neuropathic pain, improvements in sleep and anxiety have been documented alongside pain relief in the same trials.

Delivery in a Palliative Setting

Practical considerations dominate here. Patients who are nauseated cannot tolerate the smell of combusted cannabis, and those with swallowing difficulty need alternatives to capsules. We work with sublingual oils, which are absorbed easily and act for seven to eight hours, along with topical preparations for localised pain and vaporised formats where rapid onset is needed for breakthrough symptoms. Nobody is required to smoke anything.

Working With Your Care Team

Palliative patients are almost always under the care of an existing team, and cannabinoid therapy belongs inside that plan rather than beside it. We coordinate directly with treating physicians and palliative services, and we consult with families as well as patients, because at this stage they are managing the treatment together.

Consultations can be conducted by telemedicine where travelling to a clinic is not realistic.

Your Treatment Plan at Cura Vida

Palliative patients receive a comprehensive assessment focused on symptom burden and comfort rather than long-term disease management, with frequent review as needs change. Medical cannabis treatment should always be supervised by a qualified physician.